Quoin Pharmaceuticals 2024 财年每股收益 $(1.91) 优于预期 $(2.10),公司现金及现金等价物约为1410万美元,预计可资助公司运营到2026年第二季度

财报速递
13 Mar
Quoin Pharmaceuticals(NASDAQ: QNRX)报告季度每股亏损$(1.91),优于分析师一致预期的$(2.10),超出9.05%。

以上内容来自Benzinga Earnings专栏,原文如下:

Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.91) per share which beat the analyst consensus estimate of $(2.10) by 9.05 percent.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10